PH12016500414A1 - Solid preparation containing choline alfoscerate and method for preparing same - Google Patents

Solid preparation containing choline alfoscerate and method for preparing same

Info

Publication number
PH12016500414A1
PH12016500414A1 PH12016500414A PH12016500414A PH12016500414A1 PH 12016500414 A1 PH12016500414 A1 PH 12016500414A1 PH 12016500414 A PH12016500414 A PH 12016500414A PH 12016500414 A PH12016500414 A PH 12016500414A PH 12016500414 A1 PH12016500414 A1 PH 12016500414A1
Authority
PH
Philippines
Prior art keywords
solid preparation
choline alfoscerate
calcium silicate
present
preparation containing
Prior art date
Application number
PH12016500414A
Other versions
PH12016500414B1 (en
Inventor
Choi Youn Woong
Min Byung Gu
Ki Do Hyoung
Jun Hyung Joon
Choi Eun-Jung
Cho Sang Min
Ha Dae-Chul
Park Hee-Chan
Song Hee-Yong
Original Assignee
Korea United Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea United Pharm Inc filed Critical Korea United Pharm Inc
Publication of PH12016500414B1 publication Critical patent/PH12016500414B1/en
Publication of PH12016500414A1 publication Critical patent/PH12016500414A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to a solid preparation comprising choline alfoscerate and calcium silicate and a method for preparing the same, wherein calcium silicate adsorbs choline alfoscerate and thereby enables formulation in a solid form. Compared to soft capsule formulations, the solid preparation of the present invention, comprising choline alfoscerate and calcium silicate, has advantages of there being less concern regarding deterioration due to microorganisms and stability degradation due to moisture, and of being excellent in the ease of dosing because of a smaller volume. In addition, the present invention improves the initial dissolution rate of the solid preparation by using two or more disintegrants by mixture and thereby exhibits the same level of dissolution profile as conventional soft capsule formulations, and therefore is not different therefrom in the expression of a medicinal effect.
PH12016500414A 2014-07-08 2016-03-03 Solid preparation containing choline alfoscerate and method for preparing same PH12016500414A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020140085171A KR101631846B1 (en) 2014-07-08 2014-07-08 Solid preparations containing choline alfoscerate and preparing method thereof
PCT/KR2015/006764 WO2016006862A1 (en) 2014-07-08 2015-07-01 Solid preparation comprising choline alfoscerate and method for preparing same

Publications (2)

Publication Number Publication Date
PH12016500414B1 PH12016500414B1 (en) 2016-05-16
PH12016500414A1 true PH12016500414A1 (en) 2016-05-16

Family

ID=55064433

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12016500414A PH12016500414A1 (en) 2014-07-08 2016-03-03 Solid preparation containing choline alfoscerate and method for preparing same

Country Status (3)

Country Link
KR (1) KR101631846B1 (en)
PH (1) PH12016500414A1 (en)
WO (1) WO2016006862A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101898669B1 (en) 2017-02-15 2018-10-31 콜마파마(주) A pharmaceutical capsule comprising choline alfoscerate and a method preparing the same
KR102210417B1 (en) 2018-04-24 2021-02-02 한국유나이티드제약 주식회사 Liquid formulation comprising choline alfoscerate
WO2019208898A1 (en) * 2018-04-24 2019-10-31 한국유나이티드제약 주식회사 Liquid syrup preparation containing choline alfoscerate
KR102221211B1 (en) 2019-02-13 2021-03-03 한국바이오켐제약 주식회사 Method of preparing choline alfoscerate and pharmaceutical composition comprising the same
KR20210105761A (en) 2020-02-19 2021-08-27 한국프라임제약주식회사 A sustained release dosage form comprising choline alphoscerate as an active ingredient

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4782695B2 (en) * 2004-10-25 2011-09-28 日本たばこ産業株式会社 Solid preparation with improved solubility and stability and method for producing the same
KR101499533B1 (en) 2008-02-15 2015-03-09 주식회사 씨티씨바이오 Pharmaceutical preparation containing choline alfoscerate
JP5827952B2 (en) * 2009-10-09 2015-12-02 ユンジン・ファーム・カンパニー・リミテッドＹｕｎｇｊｉｎ Ｐｈａｒｍ． Ｃｏ． Ｌｔｄ． Pharmaceutical composition having both rapid action and durability
KR101172699B1 (en) 2011-05-16 2012-08-09 한국프라임제약주식회사 Pharmaceutical preparation comprising choline alfoscerate, and a method for manufacturing the same
KR101257918B1 (en) 2011-07-14 2013-04-30 주식회사 바이오파마티스 Sustained-release pharmaceutical composition comprising choline alfoscerate or pharmaceutically acceptable salt thereof and method for manufacturing the same
KR101257919B1 (en) * 2011-07-14 2013-04-30 주식회사 바이오파마티스 Solid preparation for oral administration comprising choline alfoscerate or pharmaceutically acceptable salt thereof and method for manufacturing the same

Also Published As

Publication number Publication date
PH12016500414B1 (en) 2016-05-16
KR101631846B1 (en) 2016-06-20
KR20160005971A (en) 2016-01-18
WO2016006862A1 (en) 2016-01-14

Similar Documents

Publication Publication Date Title
MX2016013486A (en) Ion channel activators and methods of use.
PH12016500414A1 (en) Solid preparation containing choline alfoscerate and method for preparing same
PH12016501581A1 (en) Benzimidazol-2-amines as midh1 inhibitors
TW201613867A (en) Difluoromethyl-nicotinic-indanyl carboxamides
MX2019015744A (en) Pharmaceutical compositions.
PH12016501807A1 (en) Novel compounds
EA201590491A1 (en) IMMUNOGENIC COMPOSITION
MD20170048A2 (en) Abiraterone acetate formulation and methods of use
PH12017501133A1 (en) Pyrazolopyridinamines
PH12018500852B1 (en) Novel cryptophycin compounds and conjugates, their preparation and their therapeutic use
PH12016502050A1 (en) Homovanillinic acid ester, in particular, for creating a hot and/or pungent taste sensation
UA116889C2 (en) COMPOSITION COMPRISING A MIXTURE OF CD95-Fc ISOFORMS
PH12020550703A1 (en) Sulfonamide compounds and use thereof
PH12016501932A1 (en) Amido-substituted azole compounds
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
PH12016501814A1 (en) Inhibitors of the wnt signalling pathways
MX2015010486A (en) Chewable composition for oral administration and process for preparing thereof.
MX2016011401A (en) Pharmaceutical compositions comprising levocetirizine.
PH12017500661A1 (en) Reduced foaming vaccine compositions
PH12017500323A1 (en) P38 map kinase inhibiting indanyl urea compounds
GEP20196944B (en) Process for preparing the inhalation formulations
TN2013000442A1 (en) FORMULATION FOR ANTI-α4β7 ANTIBODY
IN2014MU01178A (en)
IN2014MU01179A (en)
MA39762A (en) Novel compounds